AstraZeneca Will Ax Its U.S. Workers’ Pension Plan This Year

AstraZeneca Pharmaceuticals LP, a U.S. subsidiary of the company manufacturing one of the world’s most prominent Covid-19 vaccines, will terminate its $1.3 billion pension plan later this year, according to company officials.